1. Management of rheumatoid arthritis: an overview;Radu;Cells,2021
2. A review of upadacitinib in rheumatoid arthritis;Tanaka;Mod. Rheumatol.,2020
3. Management of axial spondyloarthritis-insights into upadacitinib;Braun;Drug Design Devel. Ther.,2022
4. National Center for Biotechnology Information. PubChem Compound Summary for CID 58557659, Upadacitinib. https://pubchem.ncbi.nlm.nih.gov/compound/Upadacitinib. (Accessed date: 8 May, 2024).
5. RINVOQ® (upadacitinib) extended-release tablets, for oral use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/211675s003lbl.pdf. (Accessed date: 8 May, 2024).